Aprea Therapeutics Q2 EPS $(0.58) Beats $(0.64) Estimate, Sales $561.57K Beat $50.00K Estimate
Author: Benzinga Newsdesk | August 12, 2024 08:41am
Aprea Therapeutics (NASDAQ:
APRE) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.64) by 9.38 percent. This is a 33.33 percent increase over losses of $(0.87) per share from the same period last year. The company reported quarterly sales of $561.57 thousand which beat the analyst consensus estimate of $50.00 thousand by 1.02K percent. This is a 124.91 percent increase over sales of $249.69 thousand the same period last year.
Posted In: APRE